Trexquant Investment LP Iovance Biotherapeutics, Inc. Transaction History

Trexquant Investment LP

$6.33 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $1.07 Million - $2.45 Million	140,325 New	140,325 $2.08 Million
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $576,336 - $856,688	104,220 Added 59.01%	280,846 $1.72 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $992,638 - $1.77 Million	176,626 New	176,626 $1.13 Million
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $169,073 - $260,848	-13,657 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $165,417 - $276,161	-9,995 Reduced 42.26%	13,657 $261,000
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $481,318 - $629,852	23,652 New	23,652 $583,000
Q2 2021 Aug 12, 2021	SELL	$16.33 - $33.07 $567,581 - $1.15 Million	-34,757 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $996,483 - $1.83 Million	34,757 New	34,757 $1.1 Million
Q4 2020 Feb 11, 2021	SELL	$28.04 - $50.26 $469,193 - $841,000	-16,733 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$27.75 - $36.3 $864,051 - $1.13 Million	-31,137 Reduced 65.04%	16,733 $551,000
Q2 2020 Aug 07, 2020	BUY	$27.21 - $41.0 $1.3 Million - $1.96 Million	47,870 New	47,870 $1.31 Million
Q2 2019 Aug 09, 2019	SELL	$9.78 - $24.52 $538,672 - $1.35 Million	-55,079 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$8.41 - $11.26 $463,214 - $620,189	55,079 New	55,079 $524,000
Q4 2018 Feb 13, 2019	SELL	$7.51 - $11.93 $185,737 - $295,052	-24,732 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$11.25 - $17.7 $164,452 - $258,738	14,618 Added 144.53%	24,732 $278,000
Q2 2018 Aug 07, 2018	BUY	$12.45 - $16.95 $125,919 - $171,432	10,114 New	10,114 $129,000
Q1 2018 May 03, 2018	SELL	$8.1 - $19.5 $125,258 - $301,548	-15,464 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$6.65 - $9.25 $160,437 - $223,165	-24,126 Reduced 60.94%	15,464 $124,000
Q3 2017 Nov 09, 2017	BUY	$4.45 - $8.55 $176,175 - $338,494	39,590	39,590 $307,000

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account